Fig 1: The expression levels of TH, GPX4 and FTH1 are significantly decreased in rats with PD. (A) The change in the number of rotation laps of the rats after the apomorphine (APO) injection on post-surgical day 28; the number of turns is presented as the mean ± SEM. (B) IHC was performed in the SN of the control and model group. The expression of TH was decreased in the model group. (C) The expression of GPX4 was decreased in the model group. (D) The expression of FTH1 was reduced in the model group. The ratio of positive cells was analyzed. *P<0.05, **P<0.01 and ****P<0.0001 vs. model group; scale bar, 50 µm. PD, Parkinson's disease; TH, tyrosine hydroxylase; GPX4, glutathione peroxidase 4; FTH1, ferritin heavy chain 1.
Fig 2: Deficiency of both GPX4 and vitamin E impairs hematopoietic system homeostasis.a The body weight, b spleen weight, and c total BM cell counts of the Gpx4flox/flox Vav-Cre mice were measured after 3 weeks of a VE-depleted diet. d Left panel: representative flow cytometric plots of the T cell, B cell, and myeloid cell groups in peripheral blood. Right panel: statistical data. e The number of HSPCs in the Gpx4flox/flox Vav-Cre mice after 3 weeks of a VE-depleted diet. N = at least four mice in each group. Data are the mean ± SD. (*P < 0.05, **P < 0.01, ***P < 0.001).
Fig 3: GEN inhibits MI-mediated ferroptosis. (A) Prussian blue staining of iron deposition in rat heart tissues. (B,C) MDA and GSH contents in rats of Sham, MI, MI + DFO, and MI + GEN group. (D) Expression levels of the ferroptosis marker Ptgs2 in rat heart tissues. (E) Grsf1 and GPx4 expression levels in the heart tissues. Data were expressed as mean ± SD (n = 8). *p < 0.05, **p < 0.01 vs. Sham group; # p < 0.05, ## p < 0.01 vs. MI group. Scale bar = 50 µm.
Fig 4: Silencing or inhibition of HO-1 in an appropriate range can reverse Lut-induced ferroptosis in ccRCC by restraining Fe2+ production. (a) Heme levels in 786-O cells treated under different conditions. (b) Levels of intracellular ferrous ion of 786-O cells treated under different conditions. (c) Expression levels of HO-1, GPX4, and SLC7A11 in 786-O cells treated under different conditions as determined by western blot. (d) Semiquantification of band densities in (c). Representative images (e) and semiquantitative analyses (f) of lipid peroxidant in 786-O cells treated under different conditions (magnification, ×200). (g) Interactions of Lut with HO-1 as predicted by molecular docking technology. The data in (a), (b), (d), and (f) are expressed as the mean ± SD. *P < 0.05 vs. the NC group, #P < 0.05 vs. Lut+siNC group, and &P < 0.05 vs. Lut+DMSO group. Lut: luteolin; Znpp: zinc protoporphyrin.
Fig 5: The accumulation of Fe2+ and upregulation of HO-1 are involved in Lut-induced cell death in ccRCC. Levels of intracellular ferrous Fe2+ (a) and GSH (b) of 786-O and OS-RC-2 cells treated with or without Lut for 24 h or 48 h. (c) The LDH release assay showed that Lut-induced cell death of ccRCC was alleviated in the presence of DFP, NAC, and Fer-1 and was exacerbated in the presence of FAC. (d) Expression levels of MMP2, vimentin, E-cadherin, HO-1, KEAP1, NRF2, GPX4, SLC7A11, SLC40A1, DMT1, FTL, and FTH1 in 786-O and OS-RC-2 cells treated with or without Lut for 24 h as determined by western blot analysis. (e) Semiquantification of band densities in (d). The data in (a), (b), (c), and (e) are expressed as the mean ± SD. *P < 0.05 vs. the NC group, #P < 0.05 vs. Lut group. Lut: luteolin; DFP: deferiprone; NAC: acetylcysteine; Fer-1: ferrostatin-1; FAC: ammonium iron (III) citrate.
Supplier Page from Abcam for Anti-Glutathione Peroxidase 4 antibody [EPNCIR144]